Assessing Pathological Response to Neoadjuvant Therapy in Kidney Cancer: Quality over Quantity?

Jones JO, van der Mijn JCK, Bex A, Stewart GD

DOI: 10.1016/j.euo.2026.09.006
Published: 2026 Sep 23
Container: European urology oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.euo.2026.09.006,
  title = {Assessing Pathological Response to Neoadjuvant Therapy in Kidney Cancer: Quality over Quantity?},
  author = {Jones JO and van der Mijn JCK and Bex A and Stewart GD},
  year = {2026},
  journal = {European urology oncology},
  doi = {10.1016/j.euo.2026.09.006},
  url = {https://doi.org/10.1016/j.euo.2026.09.006}
}

RIS

TY  - JOUR
TI  - Assessing Pathological Response to Neoadjuvant Therapy in Kidney Cancer: Quality over Quantity?
AU  - Jones JO
AU  - van der Mijn JCK
AU  - Bex A
AU  - Stewart GD
PY  - 2026
JO  - European urology oncology
DO  - 10.1016/j.euo.2026.09.006
UR  - https://doi.org/10.1016/j.euo.2026.09.006
ER  -

APA

JO, J., JCK, V. D. M., A, B., & GD, S. (2026). Assessing Pathological Response to Neoadjuvant Therapy in Kidney Cancer: Quality over Quantity?. European urology oncology. https://doi.org/10.1016/j.euo.2026.09.006

Source records

pubmed · retrieved 2026-09-25T23:34:22.325Z